|
|
Roy Steven Herbst, M.D.,
Ph.D.
The University of Texas MD Anderson Cancer Center
Houston, Texas
Attending Physician
Assistant Internist
Assistant Professor of Medicine
Assistant Professor of Cancer Biology
Board Certified Internal Medicine and Medical Oncology
|
|
Dr. Roy S. Herbst
has been with the M. D. Anderson Cancer Center in Houston, Texas since
1997. He has become a highly regarded physician/scientist in the
Department of Thoracic/Head and Neck Medical Oncology, and has furthered
his reputation as one of the leading researchers in the exciting field of
new drug development, especially as it relates to several novel
antiangiogenic/antimetastatic translational studies currently under his
direction.
Dr. Herbst has an
extensive educational background in molecular biophysics and biochemistry.
He received his Bachelor and Master of Science degree in molecular
biophysics and biochemistry from Yale University, Connecticut, in 1984, a
Ph.D. in molecular cell biology from The Rockefeller University, New
York, in 1990, and an M.D. from Cornell University Medical College, New
York, in 1991. He received his internship training and served his
postdoctoral Hematology fellowship at Brigham and Women's Hospital, going
on to serve as Chief Medical Oncology Resident at West Roxbury VA
Hospital, and Medical Oncology Fellow at Dana Farber Cancer Institute,
Harvard Medical School. In 1997, Dr. Herbst received an additional Master
of Science degree from Harvard Medical School through the MIT-Harvard HST
Program.
Dr. Herbst is first
author of numerous peer-reviewed scientific papers, which have had an
impact on our understanding and approach to the diagnosis and treatment
of cancer. He has served various roles as an invited guest for such
prestigious organizations as the American Association for Cancer Research
and the American Society of Clinical Oncology, Harvard Medical School,
Dana Farber Cancer Institute, and M. D. Anderson Cancer Center.
His peers have
selected him for a number of accolades and awards. The most recent awards
include the 1999 Physician Scientist Award, the 1999 American Society of
Clinical Oncology Career Development Award, 1998 and 1999 SPORE
Development Award, and the 1998 Physicians Referral Service Research
Award. In addition, in 1997, he received the American Society of Clinical
Oncology Young Investigator Award.
|
